Navigation Links
New Clues to How HIV Infects Body's Cells
Date:8/1/2012

WEDNESDAY, Aug. 1 (HealthDay News) -- Helper T-cells normally support the immune system, but a new study involving mice shows HIV-infected T-cells help transport the virus throughout the body and infect other T-cells.

Researchers from Massachusetts General Hospital said their findings could lead to improved treatments that could help control the movement of infected T-cells in the body.

"We have found that HIV disseminates in the body of an infected individual by 'hitching a ride' on the T-cells it infects," study author Dr. Thorsten Mempel, of the Massachusetts General Hospital Center for Immunology and Inflammatory Diseases, said in a hospital news release.

The researchers examined the behavior of HIV-infected human T-cells using a "humanized" mouse model, which has an essentially human immune system, according to the release.

After confirming that human T-cells enter and migrate within the animals' lymph nodes, the researchers injected them with HIV engineered to give off a green fluorescent protein, which allowed them to monitor the movement of infected cells.

They found that within two days, the HIV-infected T-cells moved more slowly than healthy T-cells. They also were evenly distributed within the lymph node, but they remained close to the injection site.

"Infected T-cells continue doing what they usually do -- migrating within and between tissues such as lymph nodes -- and in doing so they carry HIV to remote locations that the virus could not reach as easily," Mempel said. "There are drugs that can manipulate the migration of T-cells that potentially could be used to help control the spread of virus within a patient."

Ten percent to 20 percent of the HIV-infected T-cells formed long, thin extensions that trailed behind the moving cells. These elongated cells contained the HIV envelope protein, which researchers thought might cause infected cells to "tether" to uninfected cells and form these extensions.

Infected cells had multiple nuclei, the researchers found, which shows they were formed when several cells combined.

The researchers also injected a separate group of mice with HIV. This group, however, was treated with an agent that prevents T-cells from leaving the lymph nodes.

After two months, the researchers found the levels of HIV in the animals' blood and in lymph far from the injection site were much lower than the levels of the animals not treated with the agent. They noted that the agent used to suppress the migration of infected T-cells did not reduce the level of HIV in animals that already had an established HIV infection.

"While our observation of tethering interactions between infected and uninfected ... cells suggests that HIV may be transmitted between T-cells by direct contact, we will have to clearly show this in future studies and explore how important it is relative to the transmission by free virus," said Mempel, who also is an assistant professor of medicine at Harvard Medical School in Boston.

The study was published Aug. 1 in the journal Nature. Scientists note that research with animals often fails to produce similar results in humans.

More information

The U.S. Centers for Disease Control and Prevention has more about HIV and AIDS.

-- Mary Elizabeth Dallas

SOURCE: Harvard Partners, news release, Aug. 1, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study of half siblings provides genetic clues to autism
2. Ice Cream Headaches Might Offer Clues to Migraines
3. Research yields new clues to how brain cancer cells migrate and invade
4. Clues to Slacker Behavior Found in Brain, Study Says
5. Geisel researchers sift through junk to find colorectal cancer clues
6. New Clues to the Evolution of the Human Brain
7. Amazon Tribe Gives Clues to Heart-Healthy Lifestyles
8. Researchers at IRB Barcelona uncover new clues about the origin of cancer
9. Fossilized Teeth Hold Clues to Early Human Species Diet
10. Scientists discover new clues explaining tendon injury
11. New drug prevents spread of human prostate cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues to How HIV Infects Body's Cells
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: